Skip to main content

Spectrum: Autism Research News

topic /

Treatments

Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.

June 2012

SHANK2 mouse models show opposite brain signaling

by  /  25 June 2012

Two new strains of mice carrying different mutations in the SHANK2 gene show similar autism-like behaviors but opposing effects on brain signaling, according to two independent studies published 14 June in Nature.

Comments

Cognition and behavior: Context affects repetitive behavior

by  /  20 June 2012

Repetitive behaviors are often motivated by anxiety when children with autism and intellectual disability transition from one task to the next, but they are linked to a desire for attention when the children have free time, according to a study published in May in the Journal of Applied Research in Intellectual Disabilities.

Comments

Drug merger

by  /  19 June 2012

Seaside Therapeutics, a small biotech, and Swiss pharmaceutical giant Roche have announced a partnership to develop drugs for fragile X syndrome and autism.

Comments

Clinical research: Genetic variant improves effects of oxytocin

by  /  15 June 2012

Men with a common autism-linked variant of CD38, a gene that regulates levels of the ‘trust hormone’ oxytocin, benefit more from the hormone than do those with other variants, according to a study published in the May issue of Neuropsychopharmacology.

Comments

Q&A with Luca Santarelli: Targeting neuronal connections

by  /  12 June 2012

Luca Santarelli, head of neuroscience at Roche, explains why he is optimistic that pharmaceutical companies can overcome the obstacles in autism drug development.

Comments

Counting conditions

by  /  8 June 2012

A tool designed to detect psychiatric disorders in people with autism may produce more accurate estimates of co-occurring conditions.

Comments

Clinical research: Long-term studies track autism’s trajectory

by  /  6 June 2012

Two studies published over the past month followed individuals with autism at various ages and showed that they gain developmental skills differently than controls do.

Comments

Valproate fate

by  /  5 June 2012

A new rat study shows that the precise timing of early valproate exposure, an autism risk factor, can have a big influence on behavior later in development.

Comments

Immune cells sculpt brain by pruning neuronal connections

by  /  4 June 2012

Immune cells called microglia may play a central role in trimming synapses, the connections between neurons, according to research published 24 May in Neuron. These modifications are part of a normal developmental process by which excess synapses in the brain are destroyed.

Comments

Brain trust

by  /  1 June 2012

Preliminary research shows that in people with autism, oxytocin enhances activity in brain areas that process social information.

Comments